Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 78
Warning: Trying to access array offset on value of type bool in /www/wwwroot/www.medtourcn.com/wp-content/themes/medical-directory/framework/theme/medicaldirectory-image.php on line 79
Several Things Cancer Patients Need to Know Before Seeking Medical Treatment in China
What You Need to Know About Seeking Medical Treatment in China
Medical Treatment in China
China, as the world’s most populous country and the second largest economy, has been making waves in the global healthcare industry. Over the past few decades, the country has heavily invested in medical infrastructure and technology. China is renowned for its unique blend of traditional Chinese medicine and cutting-edge medical technology, attracting patients seeking various treatments from around the world.
Historically, China has been a pioneer in the field of medicine. Traditional Chinese medicine (TCM) practices such as acupuncture, herbal medicine, and Tui Na massage have been revered and utilized since ancient times. The foundational work “Huangdi Neijing,” written over two thousand years ago, still influences medical practice today. This rich cultural background adds a unique dimension to the modern medical services and therapies offered in China, allowing for the adoption of comprehensive medical approaches that appeal to those seeking traditional and alternative treatments.
In recent years, China has made significant progress in biotechnology, genomics, and pharmaceuticals. Advances in areas such as stem cell research, oncology, and orthopedics have propelled China into the forefront of global medical excellence. Chinese medical institutions are equipped with state-of-the-art technology, and many collaborate with international healthcare providers to conduct research and clinical trials, offering advanced treatment methods at a fraction of the cost compared to Western countries.
China’s uniqueness lies in its wide range of medical services. Whether you’re seeking advanced surgical procedures, traditional Chinese medicine, or a combination of both, China is your destination of choice. The geographical diversity of China also means you can combine your medical journey with travel experiences, from the bustling cities of Beijing to the tranquil mountains of Tibet, offering healing for both body and soul.
Top Medical Disciplines in China:
Oncology Treatment
Orthopedic Surgery
Cardiac Care
Traditional Chinese Medicine
Top-ranking oncology hospitals and clinics:
https://www.medtourcn.com/introducing-chinas-top-10-leading-cancer-hospitals/
To reach out or visit the best oncology hospitals in China, contact us or send the electronic version or photo of your genetic testing report and diagnosis report.
email：doctor.huang@globecancer.com
WhatsApp：+8613717959070
Cost Comparison
Prices can vary depending on the institution and the specifics of the treatment but generally fall within these ranges:
-
Price Ranges : Oncology Treatments: $10,000 – $50,000
In general, medical procedures in China cost 30% to 70% less than in the United States or Western Europe. Using CAR-T as an Example: CAR-T therapy has always been notorious for its high prices. How expensive is it exactly?
Solely considering the drugs themselves, Novartis’ Kymriah is priced the highest, exceeding 3 million RMB, while other CAR-T therapies in the United States are priced at over 2 million RMB.
In contrast, three domestically produced Chinese CAR-T therapies are all priced at less than 1.3 million RMB, only one-third of Novartis’ Kymriah. Specifically, JW Therapeutics’ Carteyva (Relmacabtagene autoleucel) is priced at 1.29 million RMB, FOSUNKITE’s Yescarta (Axicabtagene ciloleucel) at 1.2 million RMB, and FUCASO (Equecabtagene ciloleucel) by IASO Biotech at 1.166 million RMB. Moreover, just a few days ago, Inaticabtagene Autoleucel, independently developed by Juventas Biotech, has been approved for market release, marking a qualitative breakthrough in the price of domestically produced Chinese CAR-T therapies, priced at 999,000 RMB per unit.